{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:40:32Z","timestamp":1789645232383,"version":"4.0.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1111\/ced.12606","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T04:53:40Z","timestamp":1424667220000},"page":"148-151","source":"Crossref","is-referenced-by-count":10,"title":["Vemurafenib-induced hyperkeratosis of the areola treated with topical adapelene"],"prefix":"10.1093","volume":"41","author":[{"given":"E.","family":"Martinez-Garcia","sequence":"first","affiliation":[{"name":"Dorset County Hospital; Dorchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Taibjee","sequence":"additional","affiliation":[{"name":"Dorset County Hospital; Dorchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Koch","sequence":"additional","affiliation":[{"name":"Dorset County Hospital; Dorchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Osborne","sequence":"additional","affiliation":[{"name":"Dorset County Hospital; Dorchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,22]]},"reference":[{"key":"10.1111\/ced.12606-BIB0001|ced12606-cit-0001","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaad.2012.06.045","article-title":"Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma","volume":"67","author":"Boyd","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12606-BIB0002|ced12606-cit-0002","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(14)70051-8","article-title":"Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study","volume":"15","author":"Larkin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1111\/ced.12606-BIB0003|ced12606-cit-0003","first-page":"388","article-title":"Hyperkeratosen im Bereich von Mamille und Areola","volume":"8","author":"Oberste-Lehn","year":"1950","journal-title":"Haut Geschlechtskr"},{"key":"10.1111\/ced.12606-BIB0004|ced12606-cit-0004","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mjd.2002.119646","article-title":"Nevoid hyperkeratosis of the nipple and areola: a distinct entity","volume":"46","author":"Baykal","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12606-BIB0005|ced12606-cit-0005","first-page":"63","article-title":"Les hyperkeratoses de l'areola et du mamelon","volume":"28","author":"Levy-Frankel","year":"1938","journal-title":"Paris Med"},{"key":"10.1111\/ced.12606-BIB0006|ced12606-cit-0006","first-page":"1","article-title":"Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients","volume":"1","author":"Vanneste","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/ced.12606-BIB0007|ced12606-cit-0007","first-page":"27","article-title":"Appearance of new vemurafenib-associated melanocytic nevi on normal-appearing skin: case series and a review of changing or new pigmented lesions in patients with metastatic malignant melanoma after initiating treatment with vemurafenib","volume":"6","author":"Cohen","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1111\/ced.12606-BIB0008|ced12606-cit-0008","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.dld.2009.02.001","article-title":"Hyperkeratosis of nipple skin during sorafenib treatment","volume":"41","author":"Frigerio","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1111\/ced.12606-BIB0009|ced12606-cit-0009","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/DAD.0b013e3182604873","article-title":"Squamoproliferative lesions arising in the setting of BRAF inhibition","volume":"34","author":"Harvey","year":"2012","journal-title":"Am J\u00a0Dermatopathol"},{"key":"10.1111\/ced.12606-BIB0010|ced12606-cit-0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1440-0960.1999.00367.x","article-title":"Bilateral nipple hyperkeratosis treated successfully with topical isotretinoin","volume":"40","author":"Toros","year":"1999","journal-title":"Australas J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12606","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12606\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:41:07Z","timestamp":1676385667000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/41\/2\/148\/6621266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,22]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12606","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,22]]}}}